Recommended Articles
Blue Jet Healthcare has delivered a strong Q4 finish to cap off FY25. With robust traction in pharma intermediates (PI) and APIs, the company posted results that beat expectations comfortably. Yes, contrast media intermediates did slow things down a little, but overall, the growth engine looks well-fuelled for the long haul.
- 2 min read
- •
- 1,066
- •
- 18 Dec 2025
Open Your Demat Account Now!